nj.com — The U.S. Supreme Court questioned whether drugmakers must pay overtime to as many 90,000 sales representatives in a clash that pits the pharmaceutical industry against the Obama administration. Hearing arguments today in Washington, the justices grappled with a lower court's conclusion that a GlaxoSmithKline Plc unit's salespeople aren't entitled to overtime because they are exempt from a federal wage-and-hour law.